Patients and clinicians experience the frustration of cutaneous viral warts caused by
infection with the human papilloma virus (HPV). Warts appear in various forms on different …

Abstract The American Cancer Society (ACS) has developed guidelines for the use of the
prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical …

We present a transmission dynamic model that can assess the epidemiologic consequences
and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent …

Infection with human papillomavirus (HPV) is the primary cause of cervical cancer, other
anogenital cancers, genital warts, and recurrent respiratory papillomatosis. Clinical studies …

In most pathogens, multiple strains are maintained within host populations. Quantifying the
mechanisms underlying strain coexistence would aid public health planning and improve …

We assessed the cost-effectiveness of including boys vs girls alone in a pre-adolescent
vaccination programme against human papillomavirus (HPV) types 16 and 18 in Brazil …

With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …

Counseling messages for tobacco cessation, condom use, circumcision, and selective
choice in the number of sexual partners can help reduce the risk of cervical cancer. Other …

The SARS-CoV-2 pandemic is a major concern all over the world and, as vaccines became
available at the end of 2020, optimal vaccination strategies were subjected to intense …

Juvenile recurrent respiratory papillomatosis (RRP) is the most common benign neoplastic
disease of the larynx in children and adolescents and has a significant impact on patients …